Post Marketing Observational Study (PMOS) to Assess Quality of Life in Swedish Hidradenitis Suppurativa (HS) Patients

CompletedOBSERVATIONAL
Enrollment

24

Participants

Timeline

Start Date

April 7, 2016

Primary Completion Date

March 28, 2018

Study Completion Date

March 28, 2018

Conditions
Hidradenitis Suppurativa
Interventions
BIOLOGICAL

Adalimumab

Adalimumab

Trial Locations (11)

11883

Sodersjukhuset, Stockholm

17176

Karolinska Univ Sjukhuset, Solna

90185

Norrlands Universitetssjukhus, Umeå

581 85

Universitetssjukhuset Linköping, Linkoping

301 85

Hallands Hospital Halmstad, Halmstad

SE-37185

Blekinge Hospital, Karlskrona

541 85

Skaraborgs Hospital, Skövde

112 51

Kungsholmens Hudklinik, Stockholm

182 88

Danderyd Hospital, Stockholm

231 85

Trelleborg Hospital, Trelleborg

751 85

Akademiska sjukhuset, Uppsala

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AbbVie

INDUSTRY